Lucid Diagnostics
LUCD
29 hedge funds and large institutions have $2M invested in Lucid Diagnostics in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 9 closing their positions.
22% more capital invested
Capital invested by funds: $1.64M → $2M (+$363K)
0.74% more ownership
Funds ownership: 3.8% → 4.54% (+0.74%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
15% less funds holding
Funds holding: 34 → 29 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
+$350K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$54.5K |
| 3 |
Lido Advisors
Los Angeles,
California
|
+$26.2K |
| 4 |
Jane Street
New York
|
+$8.98K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$22.8K |
| 2 |
AA
Axiom Advisory
San Diego,
California
|
-$12.9K |
| 3 |
VF
Virtu Financial
New York
|
-$12K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.2K |
| 5 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$9.56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $2 | +$2 | +2 | New |
|
|
TIM
27
Thompson Investment Management
Madison,
Wisconsin
| $1 | – | – | – |
|
|
DB
28
Danske Bank
Copenhagen K,
Denmark
| $1 | +$1 | +1 | New |
|
|
TSS
29
Two Sigma Securities
New York
| – | -$22.8K | -27,753 | Closed |
|
|
AA
30
Axiom Advisory
San Diego,
California
| – | -$12.9K | -14,958 | Closed |
|
|
VF
31
Virtu Financial
New York
| – | -$12K | -14,158 | Closed |
|
|
BAM
32
Byrne Asset Management
Kingston,
New Jersey
| – | -$9.56K | -11,000 | Closed |
|
|
IAIM
33
International Assets Investment Management
Orlando,
Florida
| – | -$820 | -1,000 | Closed |
|
34
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$259 | -315 | Closed |
|
35
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$85 | -103 | Closed |
|
|
NA
36
NewEdge Advisors
New Orleans,
Louisiana
| – | -$2 | -2 | Closed |
|
LUCD Hedge Fund Activity: Q3 2024 in Review
29 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q3 2024, worth a combined $2M — up 22% from $1.64M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LUCD and 4 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Luminus Management, adding an estimated $350K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $22.8K sold.
- 29 institutional investors held Lucid Diagnostics (LUCD) as of Q3 2024, down from 34 in Q2 2024.
- Funds reported $2M of Lucid Diagnostics stock for Q3 2024, up 22% quarter-over-quarter.
- 4 funds opened new Lucid Diagnostics positions in Q3 2024 and 9 closed out, a net change of -5 holders.
- The largest Lucid Diagnostics buyer in Q3 2024 was Luminus Management, an estimated $350K added.
- The largest Lucid Diagnostics seller in Q3 2024 was Two Sigma Securities, an estimated $22.8K sold.
Based on aggregated 13F filings for Q3 2024.